Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Rowel Q Lim

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2018
Invention and Early History of Exon Skipping and Splice ModulationKenji Rowel Q Lim, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|September 1, 2020
Invention and Early History of GapmersKenji Rowel Q Lim, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Knocking Down DUX4 in Immortalized Facioscapulohumeral Muscular Dystrophy Patient-Derived Muscle CellsKenji Rowel Q Lim, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2018
Quantitative Evaluation of Exon Skipping in Immortalized Muscle Cells In VitroKenji Rowel Q Lim, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Evolution and Breakthroughs in Exon Skipping and Splice Modulation: From Inception to Clinical SuccessKenji Rowel Q Lim, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Current Strategies of Muscular Dystrophy Therapeutics: An OverviewKenji Rowel Q Lim, Toshifumi Yokota
Frontiers in Pharmacology|March 29, 2021
Genetic Approaches for the Treatment of Facioscapulohumeral Muscular DystrophyKenji Rowel Q Lim, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Quantitative Evaluation of Exon Skipping in Immortalized Muscle Cells in VitroKenji Rowel Q Lim, Toshifumi Yokota
Journal of Personalized Medicine|November 28, 2018
Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular DystrophyKenji Rowel Q Lim, Chantal Yoon, Toshifumi Yokota
The Application of Clinical Genetics|July 17, 2019
Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophyQuynh Nguyen, Kenji Rowel Q Lim, Toshifumi Yokota
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2018
Invention and Early History of Exon Skipping and Splice ModulationKenji Rowel Q Lim, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|September 1, 2020
Invention and Early History of GapmersKenji Rowel Q Lim, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Knocking Down DUX4 in Immortalized Facioscapulohumeral Muscular Dystrophy Patient-Derived Muscle CellsKenji Rowel Q Lim, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2018
Quantitative Evaluation of Exon Skipping in Immortalized Muscle Cells In VitroKenji Rowel Q Lim, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Evolution and Breakthroughs in Exon Skipping and Splice Modulation: From Inception to Clinical SuccessKenji Rowel Q Lim, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Current Strategies of Muscular Dystrophy Therapeutics: An OverviewKenji Rowel Q Lim, Toshifumi Yokota
Frontiers in Pharmacology|March 29, 2021
Genetic Approaches for the Treatment of Facioscapulohumeral Muscular DystrophyKenji Rowel Q Lim, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Quantitative Evaluation of Exon Skipping in Immortalized Muscle Cells in VitroKenji Rowel Q Lim, Toshifumi Yokota
Journal of Personalized Medicine|November 28, 2018
Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular DystrophyKenji Rowel Q Lim, Chantal Yoon, Toshifumi Yokota
The Application of Clinical Genetics|July 17, 2019
Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophyQuynh Nguyen, Kenji Rowel Q Lim, Toshifumi Yokota
Pageof 5